
Pharmanovia has announced that it will expand its neurology portfolio with the acquisition of a selection of central nervous system …

Pharmanovia and Stealth BioTherapeutics have announced that they have entered into a new licensing agreement for the marketing and further …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

